Trial · NCT03256292
Long-term Lifestyle Change and Testosterone Replacement
NCT03256292, Completed, Baylor College of Medicine
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Long-term Lifestyle Change and Testosterone Replacement. Trials, record NCT03256292. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03256292
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Long-term Lifestyle Change and Testosterone Replacement
- NCT number
- NCT03256292
- Status
- Completed
- Enrollment
- 38 participants, actual
- Lead sponsor
- Baylor College of Medicine
- Conditions
- Hypogonadism, Aging, Overweight and Obesity
- Interventions
- Testosterone replacement, lifestyle
- First posted
- 2017-08-22
- Last updated
- 2021-03-10
Source ClinicalTrials.gov
Registered outcomes38
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Physical Performance Test score | 18 month | The primary functional outcome is the modified physical performance test, which includes seven standardized tasks (walking 50 ft, putting on and removing a coat, picking up a penny, standing up from a chair, lifting a book, climbing one flight of stairs, and performing a progressive Romberg tests) plus two additional tasks (climbing up and down four flights of stairs and performing a 360-degree turn). The score for each task ranges form 0 to 4; a perfect score is 36. |
| Primary | Change in body weight | 18 month | Measured after an overnight fast using calibrated scales |
| Secondary | Change in body composition (lean mass, fat mass and bone mineral density) | 18 month | Assessed by using dual-energy x-ray absorptiometry |
| Secondary | Volumetric BMD | 18 month | Assessed by using peripheral quantitative computed tomography (pQCT) |
| Secondary | Biochemical Markers of Bone Turnover (Serum C-terminal telopeptide (CTX) | 18 month | measured by ELISA |
| Secondary | Change in prostate specific antigen | 18 month | measured in the blood |
| Secondary | Prostate Symptom Assessment | 18 month | Using the International Prostate Symptom Scoring |
| Secondary | Mood | 18 month | Using the Geriatric Depression Scale |
| Secondary | Quality of Life | 18 month | Using SF-36 and impact of weight on quality of life short form (IWQOL-lite) |
| Secondary | Sexual function | 18 month | Using the International Index of Erectile Function |
1 to 10 of 38Source ClinicalTrials.gov
See all 38 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03256292
GET https://conductscience.org/api/trials/v1/NCT03256292/registered?page=2